Therapeutic Advances in Infectious Disease (Jun 2021)

The emerging SARS-CoV-2 variants of concern

  • Adekunle Sanyaolu,
  • Chuku Okorie,
  • Aleksandra Marinkovic,
  • Nafees Haider,
  • Abu Fahad Abbasi,
  • Urooj Jaferi,
  • Stephanie Prakash,
  • Vyshnavy Balendra

DOI
https://doi.org/10.1177/20499361211024372
Journal volume & issue
Vol. 8

Abstract

Read online

Since emerging from Wuhan, China, in December of 2019, the coronavirus (SARS-CoV-2) has been causing devastating severe respiratory infections in humans worldwide. With the disease spreading faster than the medical community could contain it, death tolls increased at an alarming rate worldwide, causing the World Health Organization to officially sanction the SARS-CoV-2 outbreak as a pandemic, leading to a state of worldwide lockdown for the majority of the year 2020. There have been reports of new strains of the virus emerging in various parts of the world, with some strains displaying even greater infectivity and transmissibility. Areas of the emerging variant of concern arise from countries like the United Kingdom, South Africa, Brazil, and India. These mutations carry a lineage from N501Y, D614G, N439K, Y453F, and others, which are globally dominated by clades 20A, 20B, and 20C. This literature review intends to identify and report SARS-CoV-2 variants that are currently evolving and their disease implications.